NIH-funded research R01 grant

Investigating how certain enzymes affect the evolution of precancerous cells

Official title: Exploring the Impact of Base Deaminase Deregulation on Precancer Evolution

Funded at University of California, San Diego · NIH-11028876 · Data updated 2026-11-12

This study is looking at how two specific enzymes might affect the growth of acute myeloid leukemia (AML) by causing changes in cancer cells, and it hopes to find new ways to treat this type of blood cancer using samples from patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startDecember 1, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$444,952
NIH project number1R01CA296974-01
Project IDNIH-11028876 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients diagnosed with acute myeloid leukemia or related myeloproliferative neoplasms.

Less likely to help

Patients with other types of cancers or those not diagnosed with myeloproliferative neoplasms may not benefit from this research.

What this research studies

This research focuses on understanding the roles of specific enzymes, APOBEC3C and ADAR1, in the progression of certain blood cancers, particularly acute myeloid leukemia (AML). By studying how these enzymes contribute to genetic changes in cancer cells, the research aims to uncover mechanisms that lead to cancer stem cell generation and resistance to treatments. Patients' primary samples will be analyzed to determine the functional relevance of enzyme deregulation in cancer progression. This could provide insights into new therapeutic strategies for managing AML.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options and better outcomes for patients with acute myeloid leukemia.

How similar studies have gone: Previous research has shown promising results in understanding the role of enzyme deregulation in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Jamieson, Catriona Helen Macleod — University of California, San Diego
  • Study coordinator: Jamieson, Catriona Helen Macleod

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.